Literature DB >> 20104444

Effects of black cohosh (Cimicifuga racemosa) and estrogen on metaphyseal fracture healing in the early stage of osteoporosis in ovariectomized rats.

Leila Kolios1, Jacob Schumann, Stephan Sehmisch, Thomas Rack, Mohammed Tezval, Dana Seidlova-Wuttke, Karl-Heinz Frosch, Klaus Michael Stuermer, Ewa Klara Stuermer.   

Abstract

Osteoporosis and its accompanying, predominantly metaphyseal, fractures are a major health problem. Black cohosh (Cimicifuga racemosa) and estrogen positively influence osteoporotic bone. Both substances may improve fracture healing in early osteoporosis as well. In 48 twelve-week-old ovariectomized or, respectively, sham-operated (SHAM) rats, a standardized metaphyseal tibia osteotomy with bridging T-plate fixation was performed. During the healing process of 35 days, rats received soy-free (SHAM, osteopenic C), estrogen- (E) or Cimicifuga racemosa- (CR) supplemented diets. After sacrifice, the callus formation was analyzed with regard to biomechanical quality, morphology, quantity, time course of new bone built and gene expression. CR induced a high rate of metaphyseal callus formation. The biomechanical properties and the amount of new callus formation indicated that fracture healing was still in progress. Therefore, gene expression of osteoblasts was comparatively high. Body weight and the trabecular structure were influenced little by CR. Estrogen improved the biomechanical properties of the callus. Resistance to microfracturing was significantly enhanced in the E group and even superior to SHAM. Remodeling of the callus formation had already begun. The trabecular network and the typical endosteal fracture healing were especially improved. Osteoporotic metaphyseal fracture healing was improved by estrogen more than by Cimicifuga racemosa. The process of fracture healing occurred nearly physiologically. The generation of callus formation was supported by Cimicifuga racemosa as well, but the five-week duration of application was too short for Cimicifuga racemosa to show its complete potential. Already-initiated Cimicifuga racemosa therapy for menopausal symptoms could be continued during fracture healing without hesitation. Georg Thieme Verlag KG Stuttgart-New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20104444     DOI: 10.1055/s-0029-1240798

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  10 in total

1.  A Preliminary Study on the Effects of Black Cohosh Preparations on Bone Metabolism of Rat Models With GnRH-a-Induced Peri-Menopausal Symptoms.

Authors:  Zhenyue Qin; Zhiyong Dong; Junling Liu; Ahong Zhong; Mingyue Bao; Huihui Wang; Hongxia Yu; Shoufeng Zhang; Wendi Zhang; Li Shen; Jie Wu; Jiming Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

2.  MiR-21 nanocapsules promote early bone repair of osteoporotic fractures by stimulating the osteogenic differentiation of bone marrow mesenchymal stem cells.

Authors:  Xiaolei Sun; Xueping Li; Hongzhao Qi; Xin Hou; Jin Zhao; Xubo Yuan; Xinlong Ma
Journal:  J Orthop Translat       Date:  2020-05-19       Impact factor: 5.191

3.  The impact of low-magnitude high-frequency vibration on fracture healing is profoundly influenced by the oestrogen status in mice.

Authors:  Esther Wehrle; Astrid Liedert; Aline Heilmann; Tim Wehner; Ronny Bindl; Lena Fischer; Melanie Haffner-Luntzer; Franz Jakob; Thorsten Schinke; Michael Amling; Anita Ignatius
Journal:  Dis Model Mech       Date:  2014-11-07       Impact factor: 5.758

4.  A novel device for resistance-free biomechanical testing of the metaphysis of long bones.

Authors:  Gina Alicia Mackert; Christoph Hirche; Helmut Harhaus; Dimitra Kotsougiani; Bernd Hoener; Ulrich Kneser; Leila Harhaus
Journal:  BMC Musculoskelet Disord       Date:  2014-07-21       Impact factor: 2.362

5.  Role of the ER/NO/cGMP Signaling Pathway in the Promotion of Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells by Actaea racemosa Extract.

Authors:  Shenlan Yang; Yanping Zhou; Bo Shuai; Rui Zhu; Wei Xu; Yanran Wu; Danfang Deng; Yingying Luo
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-15       Impact factor: 2.629

6.  A systematic review of current osteoporotic metaphyseal fracture animal models.

Authors:  R M Y Wong; M H V Choy; M C M Li; K-S Leung; S K-H Chow; W-H Cheung; J C Y Cheng
Journal:  Bone Joint Res       Date:  2018-01       Impact factor: 5.853

7.  Antiosteoporotic activity of Salvadora persica sticks extract in an estrogen deficient model of osteoporosis.

Authors:  Abdel-Motaal Fouda; Amany Ragab Youssef
Journal:  Osteoporos Sarcopenia       Date:  2017-07-29

8.  A fraction of Pueraria tuberosa extract, rich in antioxidant compounds, alleviates ovariectomized-induced osteoporosis in rats and inhibits growth of breast and ovarian cancer cells.

Authors:  Swaha Satpathy; Arjun Patra; Muhammad Delwar Hussain; Mohsin Kazi; Mohammed S Aldughaim; Bharti Ahirwar
Journal:  PLoS One       Date:  2021-01-14       Impact factor: 3.240

9.  Potential antiosteoporotic agents from plants: a comprehensive review.

Authors:  Min Jia; Yan Nie; Da-Peng Cao; Yun-Yun Xue; Jie-Si Wang; Lu Zhao; Khalid Rahman; Qiao-Yan Zhang; Lu-Ping Qin
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-31       Impact factor: 2.629

10.  Plant Extracts in the Bone Repair Process: A Systematic Review.

Authors:  Lyvia Lopes Miranda; Vanessa de Paula Guimarães-Lopes; Luciana Schulthais Altoé; Mariáurea Matias Sarandy; Fabiana Cristina Silveira Alves Melo; Rômulo Dias Novaes; Reggiani Vilela Gonçalves
Journal:  Mediators Inflamm       Date:  2019-11-25       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.